Pharmarise Holdings Corporation (2796.T)
JPY 476.0
(0.85%)
JPY 476.0
(0.85%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -351 Million JPY | -205.41% |
| 2022 | 333 Million JPY | -25.5% |
| 2021 | 447 Million JPY | 4.93% |
| 2020 | 426 Million JPY | -26.17% |
| 2019 | 577 Million JPY | 2408.7% |
| 2018 | 23 Million JPY | 111.06% |
| 2017 | -208 Million JPY | -3071.43% |
| 2016 | 7 Million JPY | -98.17% |
| 2015 | 382.19 Million JPY | 67.71% |
| 2014 | 227.89 Million JPY | -38.26% |
| 2013 | 369.09 Million JPY | -61.47% |
| 2012 | 958 Million JPY | 39.69% |
| 2011 | 685.81 Million JPY | 21.82% |
| 2010 | 562.97 Million JPY | 103.55% |
| 2009 | 276.57 Million JPY | 24.3% |
| 2008 | 222.5 Million JPY | 130.52% |
| 2007 | 96.52 Million JPY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -131 Million JPY | 75.19% |
| 2023 Q2 | 150 Million JPY | 21.95% |
| 2023 Q1 | 123 Million JPY | -1.6% |
| 2023 Q4 | -528 Million JPY | -444.33% |
| 2023 Q3 | -97 Million JPY | -164.67% |
| 2023 FY | -351 Million JPY | -205.41% |
| 2022 Q3 | 136 Million JPY | 448.72% |
| 2022 FY | 333 Million JPY | -25.5% |
| 2022 Q1 | 111 Million JPY | -11.2% |
| 2022 Q2 | -39 Million JPY | -135.14% |
| 2022 Q4 | 125 Million JPY | -8.09% |
| 2021 Q4 | 125 Million JPY | 73.61% |
| 2021 Q3 | 72 Million JPY | -61.5% |
| 2021 Q2 | 187 Million JPY | 196.83% |
| 2021 Q1 | 63 Million JPY | -79.81% |
| 2021 FY | 447 Million JPY | 4.93% |
| 2020 Q2 | 182 Million JPY | 430.91% |
| 2020 FY | 426 Million JPY | -26.17% |
| 2020 Q4 | 312 Million JPY | 2500.0% |
| 2020 Q1 | -55 Million JPY | 57.03% |
| 2020 Q3 | -13 Million JPY | -107.14% |
| 2019 Q2 | 133 Million JPY | -71.21% |
| 2019 Q1 | 462 Million JPY | 247.37% |
| 2019 FY | 577 Million JPY | 2408.7% |
| 2019 Q4 | -128 Million JPY | -216.36% |
| 2019 Q3 | 110 Million JPY | -17.29% |
| 2018 Q4 | 133 Million JPY | 1800.0% |
| 2018 FY | 23 Million JPY | 111.06% |
| 2018 Q3 | 7 Million JPY | 333.33% |
| 2018 Q2 | -3 Million JPY | 97.37% |
| 2018 Q1 | -114 Million JPY | 57.14% |
| 2017 FY | -208 Million JPY | -3071.43% |
| 2017 Q3 | 90 Million JPY | -41.56% |
| 2017 Q1 | -6 Million JPY | -102.53% |
| 2017 Q2 | 154 Million JPY | 2666.67% |
| 2017 Q4 | -266 Million JPY | -395.56% |
| 2016 Q3 | -119 Million JPY | -1090.0% |
| 2016 Q1 | -101 Million JPY | 63.91% |
| 2016 Q2 | -10 Million JPY | 90.1% |
| 2016 Q4 | 237 Million JPY | 299.16% |
| 2016 FY | 7 Million JPY | -98.17% |
| 2015 Q2 | 572.87 Million JPY | 3465.98% |
| 2015 FY | 382.19 Million JPY | 67.71% |
| 2015 Q1 | 16.06 Million JPY | -81.36% |
| 2015 Q4 | -279.83 Million JPY | -482.86% |
| 2015 Q3 | 73.09 Million JPY | -87.24% |
| 2014 Q3 | 44.81 Million JPY | -58.66% |
| 2014 Q4 | 86.17 Million JPY | 92.28% |
| 2014 Q2 | 108.4 Million JPY | 1041.91% |
| 2014 Q1 | -11.5 Million JPY | -113.01% |
| 2014 FY | 227.89 Million JPY | -38.26% |
| 2013 Q2 | 51.77 Million JPY | -63.26% |
| 2013 Q3 | 87.97 Million JPY | 69.92% |
| 2013 FY | 369.09 Million JPY | -61.47% |
| 2013 Q4 | 88.43 Million JPY | 0.52% |
| 2013 Q1 | 140.91 Million JPY | -47.49% |
| 2012 Q3 | 45.91 Million JPY | -91.52% |
| 2012 Q2 | 541.47 Million JPY | 429.58% |
| 2012 Q1 | 102.24 Million JPY | -13.12% |
| 2012 FY | 958 Million JPY | 39.69% |
| 2012 Q4 | 268.37 Million JPY | 484.53% |
| 2011 Q4 | 117.68 Million JPY | -32.61% |
| 2011 FY | 685.81 Million JPY | 21.82% |
| 2011 Q2 | 172.07 Million JPY | -22.29% |
| 2011 Q3 | 174.62 Million JPY | 1.48% |
| 2011 Q1 | 221.44 Million JPY | 16.93% |
| 2010 Q3 | 143.5 Million JPY | -29.01% |
| 2010 Q4 | 189.37 Million JPY | 31.97% |
| 2010 FY | 562.97 Million JPY | 103.55% |
| 2010 Q1 | 27.94 Million JPY | -62.49% |
| 2010 Q2 | 202.15 Million JPY | 623.53% |
| 2009 Q2 | 70.77 Million JPY | 72.98% |
| 2009 Q3 | 90.39 Million JPY | 27.71% |
| 2009 FY | 276.57 Million JPY | 24.3% |
| 2009 Q1 | 40.91 Million JPY | -58.21% |
| 2009 Q4 | 74.49 Million JPY | -17.59% |
| 2008 Q3 | 79.6 Million JPY | 142.4% |
| 2008 FY | 222.5 Million JPY | 130.52% |
| 2008 Q2 | 32.84 Million JPY | 0.0% |
| 2008 Q4 | 97.91 Million JPY | 23.0% |
| 2007 FY | 96.52 Million JPY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| HEARTSEED INC | -1.47 Billion JPY | 76.179% |
| Cawachi Limited | 4.71 Billion JPY | 107.447% |
| Qol Holdings Co., Ltd. | 4.88 Billion JPY | 107.193% |
| MatsukiyoCocokara & Co. | 52.34 Billion JPY | 100.671% |
| Welcia Holdings Co., Ltd. | 26.45 Billion JPY | 101.327% |
| Create SD Holdings Co., Ltd. | 13.69 Billion JPY | 102.564% |
| NIHON CHOUZAI Co.,Ltd. | 2.55 Billion JPY | 113.749% |
| COSMOS Pharmaceutical Corporation | 24.45 Billion JPY | 101.435% |
| Tsuruha Holdings Inc. | 24.1 Billion JPY | 101.456% |
| Ohki Healthcare Holdings Co.,Ltd. | 2.21 Billion JPY | 115.882% |
| Satudora Holdings Co.,Ltd. | 470 Million JPY | 174.681% |
| Kusuri No Aoki Holdings Co., Ltd. | 12.3 Billion JPY | 102.852% |
| Medical System Network Co., Ltd. | 1.86 Billion JPY | 118.871% |
| Shinnihonseiyaku Co., Ltd. | 2.39 Billion JPY | 114.662% |
| Sugi Holdings Co.,Ltd. | 21.97 Billion JPY | 101.597% |
| YAKUODO HOLDINGS Co., Ltd. | 3.82 Billion JPY | 109.176% |
| Astena Holdings Co., Ltd. | 1.16 Billion JPY | 130.187% |
| Genky DrugStores Co., Ltd. | 6.32 Billion JPY | 105.55% |
| Ain Holdings Inc. | 11.4 Billion JPY | 103.079% |
| Sundrug Co.,Ltd. | 29.12 Billion JPY | 101.205% |